MCM
FENC icon

MAI Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

MAI Capital Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18
Closed -$111 – 2969
2026
Q1 		$111 Buy
+18
New +$139 ﹤0.01% 4739
2025
Q1 		– Sell
-200
Closed -$1.26K – 3488
2024
Q4 		$1.26K Buy
+200
New +$1.02K ﹤0.01% 3137

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

MAI Capital Management's FENC Position: Q2 2026 in Review

MAI Capital Management sold out of Fennec Pharmaceuticals (FENC) in Q2 2026, closing a stake of 18 shares — an estimated $111 sold.

MAI Capital Management first reported a position in FENC in Q4 2024 and held it in 2 quarters. The position peaked at $1.26K in Q4 2024. 105 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • MAI Capital Management reported no remaining Fennec Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 18 Fennec Pharmaceuticals shares in Q2 2026, an estimated $111.
  • MAI Capital Management first reported a position in Fennec Pharmaceuticals in Q4 2024 and held it in 2 quarters.
  • MAI Capital Management's Fennec Pharmaceuticals position peaked at $1.26K in Q4 2024.
  • 105 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.